Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Petros Pharmaceuticals Inc (PTPI)

Petros Pharmaceuticals Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Petros Pharmaceuticals Inc 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 USA

www.petrospharma.com Employees: 21 P: 973-242-0005

Description:

Petros Pharmaceuticals Inc. is a men's health company. It engages in identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders. Petros Pharmaceuticals Inc., formerly known as Neurotrope Inc., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 3,050
Enterprise Value, $K -3,020
Shares Outstanding, K 10,009
Annual Sales, $ 5,820 K
Annual Net Income, $ -8,160 K
Last Quarter Sales, $ 1,420 K
Last Quarter Net Income, $ -660 K
EBIT, $ -12,990 K
EBITDA, $ -9,570 K
60-Month Beta 2.11
% of Insider Shareholders 12.25%
% of Institutional Shareholders 12.34%
Float, K 8,783
% Float 87.75%
Short Volume Ratio 0.23

Growth:

1-Year Return -77.62%
3-Year Return -97.91%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 90.73%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.37 on 08/14/24
Next Earnings Date 11/20/24
Earnings Per Share ttm -6.90
EPS Growth vs. Prev Qtr 81.95%
EPS Growth vs. Prev Year 69.17%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 12/01/22

PTPI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -95.40%
Return-on-Assets % -27.43%
Profit Margin % -140.21%
Debt/Equity 0.71
Price/Sales 0.55
Price/Cash Flow N/A
Price/Book 0.37
Book Value/Share 0.87
Interest Coverage -14.11
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar